Intercept Pharmaceuticals Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include CSL Behring.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 1904 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 58321% increase | Employees 7,5692% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit $4.5b (FY, 2020) |
For sources of this data, please see the company profile